Medtronic said its relationship with Nutrino's FoodPrint will leverage food data analytics across its diabetes portfolio.
Roche agreed to pay $2.4 billion to acquire the remaining shares of Foundation Medicine, a company that develops genomic profiling assays to pair cancer patients with relevant treatments and clinical trials.
A Massachusetts jury backed Boston Scientific in a product liability case involving two of the company's transvaginal mesh devices.
FDA granted a de novo request for DreaMed Diabetes' Advisor Pro, an AI-based diabetes treatment decision support software.
An FDA advisory committee concluded that BTG's device for treating severe emphysema patients is safe, but the panel raised concerns about the product's efficacy and whether or not the benefits outweigh the risks.
We want to raise the profile of the young people doing groundbreaking work in the medical device and diagnostic industry. Do you know any industry innovators under the age of 30? Tell us who should make the 2018 list! Email nominations to [email protected] with the subject line: Medtech's...
Sirtex Medical said farewell to Varian on Thursday and hitched its wagon to CDH Investments, which had launched a competing bid for Sirtex in May.
An expert from Boston Scientific shares insights to help you understand your users and answers questions from industry peers on design validation.
If Stryker is, in fact, making a play for Boston Scientific, will Johnson & Johnson enter the fray if a bidding war emerges? Analysts say the chances are pretty good.
Johnson & Johnson accepted Platinum Equity's $2.1 billion offer for LifeScan,the company's blood glucose monitoring unit known for its OneTouch brand of glucose meters and insulin pumps.
Boston Scientific's shares jumped nearly 10% Monday morning after the Wall Street Journal reported that Stryker approached the company with a takeover bid.
With the East Coast's largest medtech event less than a week away, we've highlighted some of the expert-led sessions, networking opportunities, and technologies you won't want to miss during the three-day event at the Javits Center in New York City next week.